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INTRODUCTION
Atopic dermatitis (AD) is a chronic pruritic inflammatory skin 
disease caused by complex interactions among various suscep-
tibility genes, host environment, infectious agents, skin barrier 
defects, and immunological responses.1 The prevalence of AD 
has doubled or tripled in industrialized countries during the 
past three decades.2 In Korea, an increased prevalence of symp-
toms, diagnosis, and treatment of AD has been noted.3 AD of-
ten represents the first clinical manifestation of atopy in child-
hood and suggests a high risk for the development of asthma.4 
The underlying pathology of AD is complex, with interactions 
among genes and environmental factors contributing to dis-
ease manifestation.5
Histamine is released from mast cells and basophils, and is an 
important mediator in the development of allergic diseases. 
Histamine is degraded by two major metabolic pathways in-
volving the enzymes histamine N-methyltransferase (HNMT) 
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and diamine oxidase (DAO; ABP1), respectively.6 DAO may 
scavenge extracellular histamine, whereas HNMT catalyzes the 
inactivation of intracellular histamine. The HNMT gene, locat-
ed on the long arm of chromosome 2 (q22.1), is approximately 
34 kb in length, with six exons and a second intron of approxi-
mately 15 kb.7
Of the eight reported polymorphisms in HNMT, only three are 
common single nucleotide polymorphisms (SNPs): -463T>C, 
314C>T, and 939A>G.8 For 314C>T, a nonsynonymous poly-
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Purpose:  Histamine N-methyltransferase (HNMT) catalyzes one of two major histamine metabolic pathways. Histamine is a mediator of pruritus 
in atopic dermatitis (AD). The aim of this study was to evaluate the association between HNMT polymorphisms and AD in children.  Methods:  We 
genotyped 763 Korean children for allelic determinants at four polymorphic sites in the HNMT gene: -465T>C, -413C>T, 314C>T, and 939A>G. 
Genotyping was performed using a TaqMan fluorogenic 5′ nuclease assay. The functional effect of the 939A>G polymorphism was analyzed.  Re-
sults:  Of the 763 children, 520 had eczema and 542 had atopy. Distributions of the genotype and allele frequencies of the HNMT 314C>T polymor-
phism were significantly associated with non-atopic eczema (P=0.004), and those of HNMT 939A>G were significantly associated with eczema in 
the atopy groups (P=0.048). Frequency distributions of HNMT -465T>C and -413C>T were not associated with eczema. Subjects who were AA 
homozygous or AG heterozygous for 939A>G showed significantly higher immunoglobulin E levels than subjects who were GG homozygous 
(P=0.009). In U937 cells, the variant genotype reporter construct had significantly higher mRNA stability (P<0.001) and HNMT enzyme activity 
(P<0.001) than the common genotype.  Conclusions:  Polymorphisms in HNMT appear to confer susceptibility to AD in Korean children.
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morphism which results in a change from threonine to isoleu-
cine at amino acid 105, the 314T allele is associated with de-
creased enzyme activity of HNMT.8 In a study of Chinese fe-
males, -1,637T>C or -463T>C tended to be associated with de-
creased HNMT activity, and 939A>G or 1097A>T was associ-
ated with increased enzyme activity.9 In another study, the vari-
ant HNMT allele frequencies were slightly higher in patients 
with asthma and rhinitis as compared with healthy subjects.10 
In our previous study,11 the 939A>G polymorphism was signifi-
cantly associated with the acetylsalicylic acid-intolerant chron-
ic urticaria phenotype in adult patients, and the variant geno-
type of the 939A>G polymorphism showed higher mRNA sta-
bility and increased enzyme activity. However, to our knowl-
edge, there is only one study of HNMT polymorphisms in AD 
patients, which demonstrated a significant association between 
AD and 314C>T in HNMT.12
The purpose of this study was to evaluate the role of HNMT 
gene in susceptibility to AD by investigating the polymorphisms 
of this gene in Korean children with AD
MATERIALS AND METHODS
Subjects
A total of 763 children were recruited from Severance Chil-
dren’s Hospital of Yonsei University for this study. These sub-
jects included 396 children with atopic eczema, 124 children 
with non-atopic eczema, 146 atopic controls, and 97 non-atop-
ic controls.
All patients with AD were diagnosed according to the criteria 
of Hanifin and Rajka.13 We excluded children with AD who also 
had respiratory allergies. In this study, we divided patients with 
AD patients into atopic eczema and non-atopic eczema.14 Tests 
for specific immunoglobulin E (IgE) against Dermatophagoides 
pteronyssinus, Dermatophagoides farinae, egg whites, cow’s milk, 
peanuts, and soybeans were performed, as these represent six 
common allergens in Korea. Children with atopy were sensitive 
to one or more of the six common allergens, and their total IgE 
level was >150 IU/mL. The total serum IgE level of children 
without atopy was <150 IU/mL, with no detectable specific IgE 
antibodies to any of the six common allergens. Controls were 
children who visited the hospital for general health checkups 
and did not have any history of allergic or inflammatory dis-
ease. Written informed consent was obtained from all partici-
pants before enrollment in the study, which was approved by 
the Severance Hospital Institutional Review Board.
Measurement of blood eosinophils and serum total and 
specific IgE levels
Peripheral blood samples were obtained from the subjects, 
and the levels of total IgE and specific IgE against each of the six 
common antigens were measured using a fluorenzymeimmu-
noassay (CAP FEIA; Pharmacia & Upjohn Diagnostic AB, Up-
psala, Sweden) according to the manufacturer’s instructions. 
Specific IgE levels >0.35 kUA/L were considered positive. A he-
matology analyzer (NE-8000; Sysmax, Kobe, Japan) was used to 
automatically count peripheral blood eosinophils.
Genotyping and PCR amplification
Whole blood was obtained from each subject, and genomic 
DNA was extracted using a FlexiGene DNA kit (Qiagen, Valen-
cia, CA, USA). We genotyped the allelic determinants of the 763 
children at four known polymorphic sites in the HNMT gene: 
-465T>C, -413C>T, 314C>T, and 939A>G.8,9,15 Genotyping was 
performed using a TaqMan fluorogenic 5′ nuclease assay (ABI, 
Foster City, CA, USA). The polymerase chain reaction (PCR) 
contained 10 ng of genomic DNA, 2.5 μL of TaqMan Universal 
PCR Master Mix, and 0.13 μL of 40× assay mix in a final vol-
ume of 5 μL. Thermal cycle conditions were: 50°C for 2 minutes 
to activate uracil N-glycosylase and prevent carry-over contam-
ination, and 95°C for 10 minutes to activate DNA polymerase, 
followed by 45 cycles of 95°C for 15 seconds and 60°C for 1 min-
ute. All PCRs were performed in 384-well plates with a Dual 
384-Well GeneAmp PCR System 9700 (ABI). Endpoint fluores-
cence readings were performed using a Prism 7900 HT sequence 
detection system (ABI). Duplicate samples and negative con-
trols were included to ensure the accuracy of genotyping.
mRNA stability according to the 939A>G polymorphism
Two luciferase reporter constructs for the common and vari-
ant genotypes of 939A>G, which comprised a 535-bp fragment 
(from nt 880 to 1,415), were transiently transfected into a my-
elomonocytic cell line (U937) by electroporation. Briefly, 1×106 
cells were seeded in six-well plates, transfected with 2 μg of an 
enhanced green fluorescent protein (EGFP) reporter plasmid 
(pEGFP-HNMT 3′-UTR), and incubated for 18 hours. Then, ac-
tinomycin D (10 μg/mL; Sigma, St. Louis, MO, USA) was added, 
and the cells were collected at 0, 0.5, 1, 2, 4, and 6 hours. 
EGFP mRNA levels were assessed by real-time PCR using a 
thermocycler and Prism 7500HT sequence detection system 
(ABI)11. The EGFP mRNA expression level was normalized to 
that of β-actin.
EGFP protein levels were assessed by measuring fluorescence 
intensity with a Synergy HT multi-detection microplate reader 
(BioTek Instruments, Winooski, VT, USA). Fluorescence inten-
sities are given in relative fluorescence units calculated relative 
to the values of mock-treated cells. Autofluorescence of non-
transfected cells was measured as a negative control. EGFP pro-
tein expression levels were normalized to total protein concen-
tration. 
HNMT enzyme activity according to the 939A>G polymorphism
Transfection of pHNMT CDS-3′-UTR constructs into U937 cells 
and the measurement of HNMT activity in cell lysates were per-
formed as previously described.11 Radioactivity was measured 
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Table 1.  Characteristics of study subjects
Characteristic Atopic eczema  (N=396)
Non-atopic eczema 
(N=124)
Atopic non-eczema 
(N=146)
Non-atopic non-eczema 
(N=97)
P-value
Age, years (mean±SD) 6.58±3.91 4.35±3.04 10.45±2.75 9.18±3.01 <0.001
Male gender, N (%) 225 (56.8) 59 (47.6) 91 (62.3) 50 (51.5) 0.019
IgE (log IU/mL) 5.88±1.44 3.51±1.03 4.94±1.81 3.28±1.05 <0.001
Eosinophil count (log μL-1) 6.13±0.85 5.75±0.77 5.41±0.91 4.75±0.84 <0.001
Values in bold indicate statistical significance.
N, number of patients; IgE, immunoglobulin E.
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Fig. 1.  Linkage-disequilibrium structure of histamine N-methyltransferase 
(HNMT) in Koreans. The upper diagram shows the genomic structure of HNMT. 
The lower diagram shows the linkage disequilibrium (D′/r 2) among the SNPs in 
this study.
using a liquid scintillation counter (LS-3801; Beckman Instru-
ments, Irvine, CA, USA). Enzyme activity was measured as the 
formation of Nτ-methylhistamine per hour of incubation at 
37°C.
Statistical analysis
Statistical analyses were performed using SPSS ver. 11.5 (SPSS 
Inc., Chicago, IL, USA). The Chi-squared test was used to detect 
a significant departure from Hardy-Weinberg equilibrium for 
the genotype frequency of each SNP and to assess differences 
in genotype frequencies between patients and controls. SNPs 
were analyzed by logistic regression with three alternative mod-
els (co-dominant, dominant, and recessive), controlling for age 
and gender as covariates. Fisher’s exact test was used when ex-
pected cell frequencies were less than five. Differences in mean 
phenotypic values were compared using Student’s t-test. Signif-
icance was indicated by P<0.05. Bonferroni’s correction was 
used for multiple comparisons.
RESULTS
Characteristics of subjects
The characteristics of the study subjects are summarized in 
Table 1. There were significant differences in age and gender 
among the four groups (P<0.05). Total IgE levels were signifi-
cantly higher in the atopic eczema group than in the other 
groups, and were higher in the atopic control group than in the 
non-atopic eczema group or non-atopic controls (P<0.05). 
Blood eosinophils were higher in the order of: atopic eczema, 
non-atopic eczema, atopic control, and non-atopic control 
groups (P<0.05).
Genotype and allele frequencies of HNMT polymorphisms
We performed a genetic association study of four genetic 
polymorphisms of HNMT, -465T>C, -413C>T, 314C>T, and 
939A>G, among the four subject groups. The genomic struc-
ture and linkage disequilibrium of HNMT are shown in Fig. 1.
The genotype distributions of the polymorphisms in the ecze-
ma and control groups of children without atopy are showed in 
Table 2. The heterozygous CT frequency of 314C>T was signifi-
cantly higher in the non-atopic eczema group than in the non-
Table 2.  Genotype and allele frequencies of histamine N-methyltransferase 
(HNMT) polymorphisms in children without atopy
Locus Genotype
Non-atopic 
eczema  
N=124, N (%)
Non-atopic  
non-eczema 
N=97, N (%)
P-value 
OR (95% CI)
-465T>C TT 48 (38.7) 39 (41.1) 0.342
TC 58 (46.8) 43 (45.3)
CC 18 (14.5) 13 (13.7)
-413C>T CC 105 (84.7) 77 (79.4) 0.018
CT 18 (14.5) 19 (19.6)
TT 1 (0.8) 1 (1)
314C>T CC 107 (86.3) 94 (96.9) 0.004
CT 17 (13.7) 3 (3.1) 4.975
TT 0 (0) 0 (0) (1.414-17.543)
939A>G AA 59 (47.6) 50 (52.6) 0.229
AG 55 (44.4) 41 (43.2)
GG 10 (8.1) 4 (4.2)
P values were calculated using dominant models. Values in bold indicate statis-
tical significance. For multiple comparisons of genotype and allele frequencies, 
Bonferroni’s multiple adjustment was applied to the level of significance, which 
was set at P<0.0125 (0.05/4). Logistic regression analysis was applied to con-
trol for age and gender as covariables. 
N, number of patients.
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atopic control group (P=0.004). The genotype and allele fre-
quencies of the -465T>C, -413C>T and 939A>G polymor-
phisms did not differ significantly between these two groups.
Table 3 shows the genotype distributions of the polymorphisms 
in the eczema and control groups of children with atopy. The 
homozygous GG frequency of 939A>G was lower than the 
combined homozygous AA and heterozygous AG frequencies 
in the eczema group (P=0.048). There were no significant dif-
ferences in the genotype and allele frequencies of -465T>C, 
-413C>T, and 314C>T between these two groups. 
IgE level classified by genotype distribution of the HNMT 
939A>G polymorphism
Total IgE was examined according to the genotype distribution 
of the HNMT 939A>G polymorphism. In children with atopy 
(Fig. 2A), the homozygous GG genotype of 939A>G was associ-
ated with significantly lower serum total IgE, compared with 
the combined homozygous AA and heterozygous AG genotypes 
(P=0.009). In children with eczema, a significantly lower total 
IgE level was also associated with the G allele. Patients who 
were homozygous GG for the 939A>G polymorphism tended 
to have significantly lower serum total IgE (P=0.011; Fig. 2B), 
and genotypes AG and GG were associated with lower serum 
total IgE levels compared with the AA genotype (P=0.007; data 
not shown). 
Effect of the HNMT 939A>G polymorphism on mRNA stability
We examined the association of the 939A>G polymorphism 
with HNMT mRNA stability to identify the effect of the poly-
morphism on HNMT enzymatic activity. The mRNA stabilities 
of the 939A and 939G alleles were analyzed by real-time PCR in 
U937 cells transfected with each genotype (939A or 939G) in 
the pEGFP-HNMT 3′-UTR construct, after actinomycin D (10 
μg/mL) treatment. The mRNA of the 939G-fused reporter gene 
was significantly more stable than that of the 939A-fused re-
porter gene (P<0.001). As seen in Fig. 3A, after actinomycin D 
treatment, the mRNA level of the 939A-fused reporter gene rap-
idly decreased, whereas that of the 939G-fused reporter gene 
decreased only slightly. We also investigated EGFP protein ex-
pression according to the 939A>G polymorphism by measur-
ing the fluorescence signal from transfected U937 cells. The flu-
Table 3.  Genotype and allele frequencies of histamine N-methyltransferase 
(HNMT) polymorphisms in children with atopy
Locus Genotype Atopic eczema N=396, N (%)
Atopic  
non-eczema 
N=146, N (%)
P-value 
OR (95% CI)
-465T>C TT 182 (46.5) 182 (46.5) 0.896
TC 167 (42.7) 167 (42.7)
CC 42 (10.7) 42 (10.7)
-413C>T CC 331 (83.8) 331 (83.8) 0.322
CT 63 (15.9) 63 (15.9)
TT 1 (0.3) 1 (0.3)
314C>T CC 359 (90.7) 359 (90.7) 1.000
CT 37 (9.3) 37 (9.3)
TT 0 (0) 0 (0)
939A>G AA 208 (52.9) 208 (52.9) 0.048
AG 167 (42.5) 167 (42.5) 0.415
GG 18 (4.6) 18 (4.6) (0.203-0.848)
P values were calculated using dominant models. Values in bold indicate statis-
tical significance. For multiple comparisons of genotype and allele frequencies, 
Bonferroni’s multiple adjustment was applied to the level of significance, which 
was set at P<0.0125 (0.05/4). Logistic regression analysis was applied to con-
trol for age and gender as covariables. 
N, number of patients.
Fig. 2.  Immunoglobulin E (IgE) level in children with atopy classified by distri-
bution of the histamine N-methyltransferase (HNMT) 939A>G polymorphism 
in (A) children with atopy and (B) children with eczema. After Bonferroni’s cor-
rection for multiple comparisons, P<0.0166 (0.05/3) was considered to be sta-
tistically significant. Logistic regression analysis was applied to control for age 
and gender as covariables.
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Fig. 3.  Effect of the histamine N-methyltransferase (HNMT) 939A>G polymor-
phism on mRNA stability and enzyme activity. The mRNA levels of the pEGFP-
HNMT 3′-UTR reporter construct in U937 cells were assessed by real-time PCR 
after actinomycin D (10 μg/mL) treatment. (A) EGFP mRNA stability according to 
the 939A>G polymorphism. The P value was determined using repeated mea-
sures ANOVA. (B) HNMT enzyme activity was examined by measuring the for-
mation of Nτ-methylhistamine in pHNMT CDS-3′-UTR-transfected U937 cells. 
The relative enzyme activity (CPM: counts per minute) is represented as the ra-
tio of the activity to the enzyme activity in cells transfected with the empty con-
trol vector pcDNA3. The P value was determined by a Mann-Whitney test. Three 
independent determinations were performed on each sample.
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orescence intensity induced by the 939G-fused reporter gene 
was significantly higher than that induced by the 939A-fused 
reporter gene (P=0.001; data not shown).
In vitro functional study of the HNMT 939A>G polymorphism
We examined the effect of the 939A>G polymorphism on 
HNMT enzyme activity and histamine release. Enzyme activity 
was assayed by measuring the formation of Nτ-methylhistamine 
in pHNMT CDS-3′-UTR-transfected U937 cells. Cells transfect-
ed with the HNMT 939G construct showed significantly higher 
enzyme activity than cells transfected with the HNMT 939A 
construct (P<0.001; Fig. 3B). 
DISCUSSION
In this study, the effects of the HNMT -465T>C, -413C>T, 
314C>T, and 939A>G polymorphisms on AD susceptibility in 
Korean children were investigated. The genotype and allele fre-
quencies of 314C>T in HNMT were significantly associated 
with non-atopic eczema, and the genotype and allele frequen-
cies of 939A>G were associated with atopic eczema. Subjects 
with the GG genotype for 939A>G had significantly lower IgE 
levels than homozygous AA or heterozygous AG subjects. In a 
functional analysis, the variant genotype reporter construct in 
U937 cells showed significantly higher mRNA stability and 
HNMT enzyme activity than the common genotype.
The 314C>T polymorphism, previously identified as a com-
mon nonsynonymous coding SNP located in HNMT exon 4, re-
sults in a Thr105Ile amino acid change.15 The function of the 
314T allele has been determined.6,8,15,16 Genotype-phenotype 
correlation analyses in HNMT pharmacogenetic studies8,15 have 
revealed a significant association of the 314T allele with reduced 
thermal stability and decreased activity of HNMT. Based on 
these results, a role for the 314C>T polymorphism in the patho-
genesis of asthma and allergic diseases has been investigated. 
The 314C>T HNMT polymorphism was significantly associat-
ed with the asthma phenotype in Caucasian patients,16 but no 
significant association of this polymorphism with asthma, bron-
chial hyperresponsiveness, or other asthma-related phenotypes 
was detected in German children.17 Further studies also failed 
to identify an association of this polymorphism with asthma.10,18 
In our previous study of adult patients with chronic urticaria, 
there was no significant association with the 314C>T HNMT 
polymorphism.11 The only study of this polymorphism in AD 
patients suggested that the 314C>T polymorphism may confer 
an increased risk for AD.12 In the present study, the 314C>T 
polymorphism was significantly associated with non-atopic ec-
zema. The importance of histamine as a pruritic mediator in 
eczema19 may explain the association between the 314C>T 
polymorphism and non-atopic eczema. 
The 939A>G polymorphism is a common SNP in HNMT.15 A 
study in a European population reported no association be-
tween 939A>G and food allergy,20 and a study in an Indian 
population found no association of this polymorphism with 
asthma.18 In our previous study, a significant association was 
demonstrated between the 939A>G polymorphism and the 
acetylsalicylic acid-intolerant chronic urticaria phenotype.11 In 
the present study, 939A>G was associated with atopic eczema. 
The GG genotype frequency of 939A>G was lower in the atopic 
eczema group compared with the atopic control group.
Interactions of IgE with its receptors are central to the phe-
nomenon of allergy, and an elevated serum IgE level is an im-
portant diagnostic feature of AD.21 To our knowledge, no pub-
lished study has suggested an association between 939A>G in 
HNMT and the serum IgE level. Here, we detected a significant 
association between the 939A>G genotype distribution and se-
rum IgE levels. In children with atopy and in those with eczema 
regardless of atopy, the homozygous GG genotype was signifi-
cantly associated with lower serum IgE levels, compared with 
the other 939A>G genotypes. These results suggest a signifi-
cant relationship between the 939G allele and lower IgE levels. 
Although the 939A>G polymorphism in the 3′-UTR of HNMT 
has not been significantly correlated with HNMT phenotype, a 
study of a healthy Chinese population demonstrated that HNMT 
activity is modulated by the HNMT 939A>G polymorphism.9,15 
In the present study, the 939G genotype was significantly relat-
ed to higher mRNA stability, increased protein expression, and 
higher enzyme activity. This replicated a previous study, which 
demonstrated an association between the 939A>G polymor-
phism and HNMT enzyme activity in chronic urticaria patients.11
Histamine plays a key role in human allergic reactions. The in-
creased local and systemic histamine levels consistently detect-
ed in AD patients suggest an important role for histamine in the 
pathogenesis of AD.22 HNMT catalyzes one of two major hista-
mine metabolic pathways and is involved in the inactivation of 
intracellular histamine.6 Our data suggest that the 939G allele of 
the 939A>G polymorphism plays a protective role in AD by in-
creasing HNMT enzyme activity, leading to reduced histamine 
levels. This is consistent with the action of histamine as a chem-
ical mediator in the inflammation that contributes to AD disease 
pathogenesis. However, the association between the 939A>G 
polymorphism and AD phenotype became statistically insignif-
icant after multiple correction. This may be partly explained by 
the contributions of additional inflammatory mediators to AD 
pathogenesis. Recent studies have demonstrated that activated 
mast cells can induce Th2 differentiation by modulating the 
function of maturing dendritic cells, and histamine functions in 
inducing Th2-promoting dendritic cells.23,24 IgE is an end prod-
uct of the Th2 response, and thus histamine may influence IgE 
production through Th2 differentiation.23 The significant asso-
ciation of the 939G allele with lower IgE levels suggests that 
HNMT-mediated inactivation of histamine may affect serum 
IgE levels.
In conclusion, polymorphisms of the HNMT gene appear to 
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confer susceptibility to AD in Korean children.
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